We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Commentary |

Risk Stratification and Therapeutic Decision Making in Acute Coronary Syndromes

E. Magnus Ohman, MD; Christopher B. Granger, MD; Robert A. Harrington, MD; Kerry L. Lee, PhD
JAMA. 2000;284(7):876-878. doi:10.1001/jama.284.7.876.
Text Size: A A A
Published online


Management of acute coronary syndromes has advanced considerably during recent years, similar to the evolution in treatment of acute myocardial infarction (MI) in the 1980s. Then, fibrinolytic and aspirin therapy were shown to reduce mortality substantially.1 Although these therapies first were applied to all patients with suspected MI,1 those with ST-segment elevation or left bundle-branch block were shown to derive most, if not all, of the benefit.2 Accelerated tissue-type plasminogen activator (tPA) then was found to be superior to streptokinase in the Global Utilization of Streptokinase and tPA for Occluded Coronary Arteries (GUSTO-I) trial, with a relative 14% reduction in 30-day mortality.3 Mortality models suggested that tPA treatment independently predicted better outcomes, consistent across patient subgroups regardless of absolute risk.4 Without a heterogeneous treatment effect, the interpretation was that almost all patients with MI would benefit from tPA treatment.

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

102 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Collections
PubMed Articles

The Rational Clinical Examination: Evidence-Based Clinical Diagnosis
Multivariate Findings for ACI Syndromes

The Rational Clinical Examination: Evidence-Based Clinical Diagnosis
Evidence Summary and Review 2